Expanding Advanced Wound Care Will Fuel Secular Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
22 Aug 25
Updated
22 Aug 25
AnalystHighTarget's Fair Value
US$9.00
45.7% undervalued intrinsic discount22 Aug
US$4.89
1Y
66.9%7D
3.4%